 AUSTIN, TX and DURHAM, NC, Oct. 01, 2021 GLOBE NEWSWIRE -- Shattuck Labs, Inc. Shattuck NASDAQ: STTK, a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced it will present four posters at SITCs 36th Annual Meeting being held Wednesday, November 10, 2021 to Sunday, November 14, 2021. 